Pharma

By Bill Siwicki February 22, 2017
Medisafe, a technology vendor that markets a personalized medication management platform, has unveiled at HIMSS17 a new feature that alerts users of possible drug-to-drug interactions that may cause unexpected side effects and/or alter the way medications perform. The interactions feature also includes disclosures when medications have other lifestyle implications, such as interactions with...
By Naomi Fried February 10, 2017
About the author: Naomi Fried, PhD (@NaomiFried), is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation infrastructure consulting to healthcare stakeholders including pharma companies and providers. Her previous positions include the first Chief Innovation Officer at Boston Children’s Hospital, Biogen’s VP of Innovation and External Partnerships, and VP...
By Heather Mack February 8, 2017
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...
By Heather Mack February 2, 2017
Roche has selected two health technology companies to deploy a wireless wearable system in a clinical trial on a drug for infants with spinal muscular atrophy. The study will use BioRadio, a wireless wearable data acquisition system from Great Lakes NeuroTechnologies that records respiratory and pulmonary data from infants in near real time. Vivonoetics’ VivoSense software works in collaboration...
By Jonah Comstock February 1, 2017
Austin, Texas-based RxWiki, which offers a medication encyclopedia written and edited by pharmacists as well as tools to help community pharmacists to communicate with consumers, has merged with TeleManager Technologies, a Newark, New Jersey-based provider of interactive voice response (IVR) and telecommunication technologies for pharmacies. The two companies will operate under the new name...
By Jonah Comstock January 19, 2017
Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin. The clearance is for prescription use, but includes two versions of the app: Go Dose, for patients, and Go Dose Pro, for healthcare providers. "...
By Jonah Comstock January 13, 2017
In 2016, we rounded up pharma news in the first, second, and third quarter of the year. Pharma news in the fourth quarter of 2016 mostly fit into two buckets: clinical trial data collection and chronic condition management. The latter focused especially on the diabetes and chronic respiratory disease spaces. Read on below for Q4 2016 news from a number of pharma companies from around the world....
By Heather Mack January 9, 2017
Mountain View, California-based Glooko is collaborating with Danish pharmaceutical company Novo Nordisk to develop a digital diabetes management platform. The non-exclusive partnership, developed and branded by both companies, will combine Glooko’s digital capabilities and Novo Nordisk’s deep knowledge of diabetes. Glooko offers a mobile, cloud-based platform for people with diabetes to track and...
By Jonah Comstock January 5, 2017
Cambridge-based MC10, which makes paper-thin adhesive health sensors, and Belgium-based pharma company UCB have completed the Parkinson's study they began in 2014 and are aiming to publish the results later this year, the two companies announced. The study used MC10's adhesive sensors to collect movement data on Parkinson's patients, combined with patient-reported outcomes and neurological...
By Jonah Comstock December 14, 2016
Exco InTouch, a Nottingham, England-based clinical trial technology vendor responsible for powering early, influential mobile-enabled trials, has been acquired. ERT, a 45-year-old global clinical trial services company, purchased Exco last week for an undisclosed amount. While both companies provide technology and services to support clinical trials, their focus areas are different, with ERT...